Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy.
Overview
- Department of Oncology, Third Xiangya Hospital, Central South University, Changsha, China
- Department of Pathology, Third Xiangya Hospital, Central South University, Changsha, China
- Department of Neurosurgery, Third Xiangya Hospital, Central South University, Changsha, China
Abstract
The abstract is not reproduced here: the paper's license (CC BY-NC-ND) does not allow it. Read it in the paper, at the publisher or on Europe PMC.
Code
No file of the authors' code could be read here: it is described below, and read at its source.
jianguoyun.com/p/dzy6btiqjnlpchiz6oogiaa](https:
Availability: 1 check, the latest on 29 September 2026: the link answers (HTTP 200)
- 29 September 2026: the link answers (HTTP 200)
The paper's code and data availability statement is in the Data section.
Tracing map
Proposed by the machine: these links were found in the paper and verified at the source, without human review. The map will receive a Zenodo DOI once one of the paper's authors has validated it with their ORCID.
What the map holds:
- 1 repository of the authors' code, each at its verified commit, with its license and how the link was found in the paper;
- 0 scripts, each with its path and the digest of its content;
- no match between paragraphs and code yet;
- neither the text of the paper nor the code itself.
Its JSON (tracing-map.json) is deposited on Zenodo with its DOI once the map is validated.
Data
No dataset and no data link were found in the paper.
Code and data availability statement
The paper has a code and data availability statement. Its license (CC BY-NC-ND) does not allow reproducing it here; in short, from what the harvester recognized in it:
- it points to the authors' code: jianguoyun.com/
p/ dzy6btiqjnlpchiz6oogiaa] (https:
Read it in the paper: doi.org/10.1007/s12672-026-04935-z.
Versions
The history of this record: each version stored by the harvester or made by a correction of its authors or of the maintainers of its code, and what changed in its facts. The texts of the paper (its abstract, its availability statements) are not part of it; versions that changed only those are not listed.
Version 1, 29 September 2026: the first record
Recorded: type, language, journal, volume, issue, pages, dates, 8 authors, 5 keywords, 6 funders, 26 references.
Cite
This paper
Tan, Y., Zeng, L., Zhang, G., Fang, J., Yin, Z., Deng, W., Cao, K., & Jiang, J. (2026). Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy. Discover oncology, 17(1), 844. https://
BibTeX
@article{tan2026developm
author = {Tan, Yiqi and Zeng, Le and Zhang, Ganghua and Fang, Jianing and Yin, Zhijing and Deng, Wenzhi and Cao, Ke and Jiang, Jiaode},
title = {{Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy}},
journal = {Discover oncology},
year = {2026},
month = apr,
volume = {17},
number = {1},
pages = {844},
publisher = {Springer},
issn = {2730-6011},
doi = {10.1007/
url = {https://
pmid = {42014657},
pmcid = {PMC13234030}
}
RIS
TY - JOUR
AU - Tan, Yiqi
AU - Zeng, Le
AU - Zhang, Ganghua
AU - Fang, Jianing
AU - Yin, Zhijing
AU - Deng, Wenzhi
AU - Cao, Ke
AU - Jiang, Jiaode
TI - Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy
T2 - Discover oncology
J2 - Discov Oncol
PY - 2026
DA - 2026/
VL - 17
IS - 1
SP - 844
SN - 2730-6011
PB - Springer
DO - 10.1007/
UR - https://
LA - en
ER -
CSL-JSON
{
"id": "10.1007/
"type": "article-journal",
"title": "Development of a metabolic subtype classifier for low-grade glioma to guide precision therapy",
"container-title": "Discover oncology",
"author": [
{
"family": "Tan",
"given": "Yiqi"
},
{
"family": "Zeng",
"given": "Le"
},
{
"family": "Zhang",
"given": "Ganghua"
},
{
"family": "Fang",
"given": "Jianing"
},
{
"family": "Yin",
"given": "Zhijing"
},
{
"family": "Deng",
"given": "Wenzhi"
},
{
"family": "Cao",
"given": "Ke"
},
{
"family": "Jiang",
"given": "Jiaode"
}
],
"container-title-short":
"volume": "17",
"issue": "1",
"page": "844",
"DOI": "10.1007/
"PMID": "42014657",
"PMCID": "PMC13234030",
"ISSN": "2730-6011",
"publisher": "Springer",
"URL": "https://
"language": "en",
"issued": {
"date-parts": [
[
2026,
4,
21
]
]
}
}
The tracing map gets a citation of its own once an author has validated it and it has a DOI.
Similar papers
The papers with a page that share the most with this one: the tools found in their code, their categories, datasets, cited references and authors, the rarest counting most.
- [1] doi:10.1111/jcmm.71154
- Mitophagy-Oxidative Stress Molecular Subtypes Define an Immunosuppressive Ecosystem and Vulnerabilities in Glioblastoma.Journal: Journal of cellular and molecular medicineIn common: other condition, 3 references
- [2] doi:10.3390/cancers18132092
- TGFB2 as a Prognostic Biomarker Associated with Myeloid-Enriched, Multi-Checkpoint-Activat
ed Immunosuppression in Diffuse Glioma: A Multi-Cohort Transcriptomic Study. Journal: CancersIn common: other condition, 3 references - [3] doi:10.3390/biology15080633
- Development and Validation of a Toxoplasma Infection-Associated Risk Model for Prognostic Stratification and Treatment Guidance in Glioma.Journal: BiologyIn common: clinical / translational, other condition, 2 references
- [4] doi:10.1016/j.isci.2026.115982 [code]
- Multi-omics profiling-derived signature links cellular ecosystem to glioblastoma prognosis.Journal: iScienceIn common: other condition, 2 references
- [5] doi:10.3390/ijms27167240
- 1-Piperidine Propionic Acid Inhibits PAR2/
SerpinB3 Signaling and Reduces Glioblastoma Tumor Aggressiveness. Journal: International journal of molecular sciencesIn common: other condition, 2 references - [6] doi:10.1080/17501911.2026.2691031
- Promoter methylation-associated brain-enriched long noncoding RNAs in glioblastoma: a multi-cohort public epigenomic re-analysis.Journal: EpigenomicsIn common: other condition, 2 references
- [7] doi:10.1186/s12967-026-08266-z [code]
- Single-cell multi-omic integration analysis prioritizes druggable genes and reveals cell-type-specific causal effects in glioblastomagenesis.Journal: Journal of translational medicineIn common: other condition, 2 references
- [8] doi:10.1186/s40478-026-02318-7
- Glioblastoma cells utilize evolutionarily adapted cell metabolism to promote their malignant proliferation.Journal: Acta neuropathologica communicationsIn common: other condition, 2 references
- [9] doi:10.1016/j.isci.2026.115657 [code]
- Integration of machine learning to develop a disulfidptosis model for predicting glioma prognosis, immunotherapy response, and drug.Journal: iScienceIn common: clinical / translational, other condition, 1 reference
- [10] doi:10.3390/biology15141179
- Transcriptomic Evidence Identifies Two TMBIM Subgroups with Opposing Prognostic Associations in Glioma.Journal: BiologyIn common: clinical / translational, other condition, 1 reference
Contribute
The authors of this paper can claim it, correct its record and validate its tracing map, and the maintainers of its code (its owner, or a public member of its organization) correct what it says of their repository; anyone signed in can ask for its removal. Every request goes to OSCR's own machine, which answers it; your account page follows them.
Sign in with ORCID to claim this paper as one of its authors, correct its record or validate its tracing map: when the paper's metadata lists your ORCID iD, you are recognized at once. Maintainers of its code: sign in with GitHub, then claim the repository on your account page.
Claim this paper
Correct its record
Say what each link of this record is, remove the ones that are not the paper's, add the ones that are missing. The correction becomes a new version of the record, in its Versions section.
Validate its tracing map
You validate the map as this page shows it: 1 repository of the authors' code, each at its verified commit and with its license, 0 scripts, and 0 matches between paragraphs and code (see the Code and Map sections). It then receives a DOI on Zenodo, with you (your ORCID iD) and OSCR as its creators; the code itself is not deposited.
The map's fingerprint: sha256:d080d8b1f599f39d…
Add the badge to its README
The badge links the code to this page. Copy one of these into the README of the paper's code: only you decide where it goes, and nothing is changed for you.
Markdown
[.
Discussion, reproductions, activity
Discussion: questions and error reports about this paper and its code, from signed-in readers and its authors. It opens with sign-in.
Reproductions: reports from readers who ran the authors' code: what they reproduced, with which environment, commit and data. It opens with sign-in.
Activity: what happens around this paper: new versions of its record, its map's validation, discussions and reproductions. It opens with sign-in.